Category: Biopharmaceuticals
Europe Biopharmaceuticals
-
2025 Europe Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3210 Read More
-
2025 Germany Biosimilars Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3695 Read More
-
2025 Europe Biosimilars Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3695 Read More
-
2025 Germany Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3205 Read More
-
2025 United Kingdom Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3205 Read More
-
2025 United Kingdom Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3210 Read More
-
2025 United Kingdom Biosimilars Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3695 Read More
-
2025 Europe Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3205 Read More
-
2025 Germany Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS BIO3210 Read More
-
Single-use Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... risk, making them a popular choice for applications in drug discovery, vaccine production, and biofuel development. Market Overview The single-use bioreactors market is anticipated to grow at a CAGR of 16.19% throughout the forecast period, ... Read More
-
Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), by End User (Biotechnology Companies, Biopharmaceutical Companies, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... in area. Cell-wall-associated proteins are key components in cell expansion process. Expansions increase wall extensibility, presumably by breaking non covalent bonds between wall polysaccharides. Due to growing demand for regenerative drugs offering faster outcomes and ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... gastrointestinal endoscopy devices along with development of novel drugs for gastrointestinal issues can also drive the market growth. Various market players are engaged in new product launches and expansions to cater to increasing needs of ... Read More
-
Pegfilgrastim Biosimilars Market, By Product (Pegfilgrastim Biosimilars and Pegfilgrastim Reference Product), By Application (Oncology, Chronic Neutropenia, Stem Cell Transplantation, Others), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... differences in terms of safety, purity, and potency from the original version of pegfilgrastim, when administered at the same dose. Biosimilars provide a cost-effective alternative to innovative biologics and expand access to important medicines for ... Read More
-
Healthcare Distribution Market, By Product Type (Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Service, and Medical Devices Distribution Services), By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... have enabled reliable transportation and storage of temperature sensitive medications and equipment. However, concerns over maintaining uninterrupted cold chains and ensuring quality of delivered products can hamper the market growth. Ongoing medical innovations and adoption ... Read More
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... debris and components, concentration to separate and recover the target product by reducing volume, and final purification using chromatographic techniques. Downstream processing plays a critical role in ensuring the purity, quality, and stability of biopharmaceutical ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... They provide benefits such as reducing the risks of cross-contamination, minimized clean-in-place and sterilization cycles, and lower capital costs. With rising demand for biologics in the biopharmaceutical industry, more manufacturers are adopting single-use technologies to ... Read More
-
Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobank, IVF clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and ... Read More
-
Biosimilars Market Research Report By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Growth Hormones), By Application (Oncology, Diabetes, Autoimmune Diseases, Chronic Inflammatory Diseases), By End Use (Hospitals, Clinics, Homecare, Research Institutions), By Manufacturing Process (Recombinant DNA Technology, Hybridoma Technology, Transgenic Technology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Industry Forecast to 2032
... of approximately 15.49%. Key factors that are driving the biosimilars market include the increasing prevalence of chronic diseases and the increasing demand for affordable biologic treatments. Biosimilars provide a cost-effective alternative that can enhance patient ... Read More
-
Biosimilars Market, By Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins Erythropoietin, Monoclonal Antibodies, Follitropin, Others), By Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... significant cost savings as compared to reference biologics. For example, Filgrastim’s biosimilar Zarzio was launched at a 15% lower price compared to original biologic Neupogen. Regulatory approvals for biosimilars have also increased in major markets ... Read More
-
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast ... Read More
-
Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035
... CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been distributed across the following segments: Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide ... Read More
-
US and Europe Pharma and Biotech Cro Market Research Report by Service Type (Clinical Development Services, Formulation Development Services, Pharmacovigilance Services, Laboratory Services, Consulting Services, Data Management Services, and Others), by Phase {Based on phase, the US and Europe Pharma and Biotech CRO Market has been segmented into Phase I, Phase II, Phase III, Phase IV. and Post Marketing Studies (PMS)}, by Indication 9 Based on Indication, the US and Europe Pharma and Biotech CRO Market has been segmented into cardiovascular, oncology, dermatology, gynecology, neurology, respiratory diseases, orthopedics, ophthalmology and others), by End User (Pharmaceutical Companies, and Biopharmaceutical Companies) Industry Forecast to 2032
... pharmaceutical and biotechnology industries by providing outsourced services such as drug development, clinical trials, regulatory affairs, and more. These include drug development, clinical trials, regulatory affairs, and post-market surveillance. CROs help streamline the drug development ... Read More
-
Clinical Trials Outsourcing Market Size, Share, and Analysis, By Phase (Phase I, Phase II, Phase III, Phase IV), By Application (Cancer, Cardiovascular Diseases, Nervous System Diseases, Infectious Diseases, Musculoskeletal Disease, Gastroenterology Diseases, and Others), By Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
2024 Germany Bio-Pharma Logistics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
Research Assistance
